Replimune Group, Inc. (REPL) vs Y-mAbs Therapeutics, Inc. (YMAB)
Detailed comparison between Replimune Group, Inc., Y-mAbs Therapeutics, Inc..Total Return (%)
Replimune Group, Inc. (REPL)Y-mAbs Therapeutics, Inc. (YMAB)
Which stock do you think will perform better?
Replimune Group, Inc.
REPL
Y-mAbs Therapeutics, Inc.
YMAB
| Metric | Replimune Group, Inc. (REPL) | Y-mAbs Therapeutics, Inc. (YMAB) |
|---|---|---|
| Current Price | $7.99 | $3.98 |
| Change | 0.83 (11.59%) | 0.10 (2.72%) |
| Market Cap | $0.62B | $0.18B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -2.97 | -6.87 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $17.00 | $16.11 |
| 52-Week Low | $4.92 | $3.76 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-3.07 | $-0.67 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| REPL | 9.30% | -27.76% | 18.72% | -56.39% | -47.29% | -47.29% |
| YMAB | -10.45% | -42.16% | -69.04% | -89.86% | -83.40% | -83.40% |